Explore key insights from ICON's Q4 2024 earnings call, including bookings growth, digital innovation, and strategic partnerships driving 2025 growth targets.
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
The launch of the AP3X token and PRIME Chain advance Apex Fusion’s goal of unifying blockchain ecosystems and enabling web3 networks to work in harmony. This will accelerate the creation of powerful ...
Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that Nelly will be headlining ...
Britain has started supplying Ukraine with surface-to-air missiles that can be launched from shipping containers. The new ...